Bio-Gene Technology Limited (ASX:BGT)
Australia
· Delayed Price · Currency is AUD 0.0350
0.00 (0.00%)
Mar 9, 2026, 3:03 PM AEST
Bio-Gene Technology Market Cap
Bio-Gene Technology has a market cap or net worth of 10.68 million as of March 9, 2026. Its market cap has increased by 12.82% in one year.
Market Cap
10.68M
Enterprise Value
9.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since November 29, 2017, Bio-Gene Technology's market cap has decreased from 20.89M to 10.68M, a decrease of -48.89%. That is a compound annual growth rate of -7.79%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AdAlta | 11.47M |
| Tissue Repair | 9.98M |
| Immuron | 9.80M |
| Invex Therapeutics | 9.02M |
| Chimeric Therapeutics | 8.84M |
| Biotron | 8.11M |
| Neurotech International | 16.85M |
| Patrys | 18.74M |